Question 1
A brand's share of its therapy area rose from 18.0% to 22.5% over the year. Which statement describes the change correctly?
Show answer & explanation
Correct answer: D - An increase of 4.5 percentage points, and of 25% in relative terms
10 exam-style questions with answers and explanations, straight from our 1,030-question bank. Tap an answer to check yourself. When you're ready, take the scored version in the free practice test.
These 10 free MERCK questions are organized by exam domain, so you can see how each part of the Merck Assessment Test blueprint is tested. Reveal the answer and explanation under each question.
A brand's share of its therapy area rose from 18.0% to 22.5% over the year. Which statement describes the change correctly?
Correct answer: D - An increase of 4.5 percentage points, and of 25% in relative terms
A company reports full-year worldwide sales of $65.0 billion, described as 1% growth as reported and 2% growth excluding the impact of foreign exchange. What does the difference between the two figures indicate?
Correct answer: A - Currency movements reduced reported growth by roughly one percentage point
A company reports the following full-year sales against the prior year: Oncology $31.7bn (up 7%), Vaccines $5.2bn (down 39%), Animal Health $6.4bn (up 8%). Which segment recorded the LARGEST absolute change in sales versus the prior year?
Correct answer: B - Vaccines, with a decrease of roughly $3.3 billion
Passage: In a randomised trial, patients receiving the investigational regimen showed a higher objective response rate than those receiving the control regimen, and the difference reached statistical significance. The authors noted that overall survival data were not yet mature and that longer follow-up would be required before conclusions on survival could be drawn. Which statement is supported by the passage?
Correct answer: D - The regimen produced a higher response rate than the control in this trial
Passage: The regulator has indicated that manufacturers may be required to submit additional stability data when a change to an approved manufacturing process is proposed. A timeline for implementation has not been announced. Which of the following can be concluded from the passage?
Correct answer: C - Additional stability data may be requested when a process change is proposed
A site operates under the rule: "A batch is released only if the quality review has been completed." A particular batch has not been released. Which conclusion follows necessarily?
Correct answer: C - Nothing about the quality review can be concluded
All operators on the line have completed the aseptic training. Some of those who have completed the aseptic training hold a supervisor qualification. Which conclusion MUST be true?
Correct answer: C - Every operator on the line has completed the aseptic training
During a routine call about supply, a pharmacist mentions in passing that a patient taking one of the company's medicines developed a persistent rash. She adds that she doubts it was related to the medicine and that the patient has since recovered. Which action by the employee would be MOST effective?
Correct answer: D - Report it through the company's adverse event process despite the doubts about causality
At a conference, a physician asks a representative whether the company's product has shown benefit in a patient population not covered by the approved labelling. The representative has read a published abstract suggesting that it may. What is the MOST appropriate response?
Correct answer: B - State that this falls outside the approved label and route the question to Medical Information
A technician completed a processing step at 09:00 but was called away before recording it. Returning at 11:00, they realise the batch record entry is missing. Which action is MOST appropriate?
Correct answer: C - Make a late entry showing when the step was performed and when it was recorded
The full bank has 1,020 more MERCK questions with explanations.
Continue in the free practice test →
View plans